S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Sysmex (SSMXY) Earnings Date, Estimates & Call Transcripts

$15.02
-0.68 (-4.33%)
(As of 04/19/2024 08:52 PM ET)

Earnings Summary

Latest
Earnings Date
Feb. 9Estimated
Actual EPS
(Feb. 9)
$0.13 Missed By -$0.03
Consensus EPS
(Feb. 9)
$0.16
Skip Charts & View Estimated and Actual Earnings Data

SSMXY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SSMXY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sysmex Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.53 EPS
Next Year EPS Consensus Estimate: $0.64 EPS

SSMXY Earnings Date and Information

Sysmex last announced its earnings data on February 9th, 2024. The reported $0.13 EPS for the quarter, missing the consensus estimate of $0.16 by $0.03. The business earned $770.84 million during the quarter. Sysmex has generated $0.51 earnings per share over the last year ($0.51 diluted earnings per share) and currently has a price-to-earnings ratio of 29.6. Earnings for Sysmex are expected to grow by 20.75% in the coming year, from $0.53 to $0.64 per share.

Sysmex Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/9/2024Q4 2023$0.16$0.1333($0.0267)$0.20-$770.84 million
11/8/2023Q2 2024-$0.1467+$0.1467$0.22-$812.16 million
8/8/2023Q1 2024-$0.10+$0.10$0.15-$694.73 million
5/11/2023Q4 2023-$0.1267+$0.1267$0.19-$845.12 million
2/9/2023Q3 2023-$0.1267+$0.1267$0.19-$742.47 million
11/9/2022Q2 2023-$0.1867+$0.1867$0.28-$782.19 million
8/4/2022Q1 2023-$0.10+$0.10$0.15-$662.42 million
5/12/2022Q4 2022-$0.1533+$0.1533$0.23-$902.69 million
2/10/2022Q3 2022-$0.1467+$0.1467$0.22-$793.48 million
11/10/2021Q2 2022-$0.18+$0.18$0.27-$812.02 million
8/6/2021Q1 2022-$0.1467+$0.1467$0.22$697.27 million$725.06 million
5/12/2021Q4 2021-$0.1467+$0.1467$0.22-$879.76 million

Sysmex Earnings - Frequently Asked Questions

When did Sysmex announce their last quarterly earnings?

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earning data on Friday, February 9, 2024. Learn more on SSMXY's earnings history.

Did Sysmex beat their earnings estimates last quarter?

In the previous quarter, Sysmex (OTCMKTS:SSMXY) missed the analysts' consensus estimate of $0.16 by $0.03 with a reported earnings per share (EPS) of $0.13. Learn more on analysts' earnings estimate vs. SSMXY's actual earnings.

How much revenue does Sysmex generate each year?

Sysmex (OTCMKTS:SSMXY) has a recorded annual revenue of $3.04 billion.

How much profit does Sysmex generate each year?

Sysmex (OTCMKTS:SSMXY) has a recorded net income of $338.80 million. SSMXY has generated $0.51 earnings per share over the last four quarters.

What is Sysmex's price-to-earnings ratio?

Sysmex (OTCMKTS:SSMXY) has a trailing price-to-earnings ratio of 29.65 and a forward price-to-earnings ratio of 28.34.

What is Sysmex's EPS forecast for next year?

Sysmex's earnings are expected to grow from $0.53 per share to $0.64 per share in the next year, which is a 20.75% increase.


More Earnings Resources from MarketBeat

This page (OTCMKTS:SSMXY) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners